Paritaprevir
Generic Name: paritaprevir
Manufactured by ABBVIE. Dosage form: TABLET, EXTENDED RELEASE. Route: ORAL. Active ingredients: DASABUVIR SODIUM (EQ 200MG BASE); OMBITASVIR (8.33MG); PARITAPREVIR (50MG); RITONAVIR (33.33MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**). Application: NDA208624.
Overview
Manufactured by ABBVIE. Dosage form: TABLET, EXTENDED RELEASE. Route: ORAL. Active ingredients: DASABUVIR SODIUM (EQ 200MG BASE); OMBITASVIR (8.33MG); PARITAPREVIR (50MG); RITONAVIR (33.33MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**). Application: NDA208624.
Dosage
Available as tablet, extended release for oral use.
Related Medications
Hamamelis Combination
hamamelis combination
*Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.
Arformoterol Tartrate Form D
arformoterol tartrate form d
Dosage form: POWDER. Active ingredients: ARFORMOTEROL TARTRATE (1 kg/kg). Category: BULK INGREDIENT.
Dextromethorphan Hydrobromide And Guaifenesin
dextromethorphan hydrobromide and guaifenesin
Expectorant [EPC]
Helps loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.